Sera Prognostics SERA Stock
Sera Prognostics Price Chart
Sera Prognostics SERA Financial and Trading Overview
| Sera Prognostics stock price | 2 USD |
| Previous Close | 2.04 USD |
| Open | 2.04 USD |
| Bid | 1.4 USD x 200 |
| Ask | 2.59 USD x 200 |
| Day's Range | 2.04 - 2.12 USD |
| 52 Week Range | 1.56 - 3.95 USD |
| Volume | 21.8K USD |
| Avg. Volume | 29.33K USD |
| Market Cap | 82.45M USD |
| Beta (5Y Monthly) | 0.983 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.67 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.5 USD |
SERA Valuation Measures
| Enterprise Value | 39.01M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.9065416 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1177.8483 |
| Price/Book (mrq) | 1.3877821 |
| Enterprise Value/Revenue | 557.22 |
| Enterprise Value/EBITDA | -1.067 |
Trading Information
Sera Prognostics Stock Price History
| Beta (5Y Monthly) | 0.983 |
| 52-Week Change | -37.23% |
| S&P500 52-Week Change | 14.15% |
| 52 Week High | 3.95 USD |
| 52 Week Low | 1.56 USD |
| 50-Day Moving Average | 2.05 USD |
| 200-Day Moving Average | 2.27 USD |
SERA Share Statistics
| Avg. Volume (3 month) | 29.33K USD |
| Avg. Daily Volume (10-Days) | 18.1K USD |
| Shares Outstanding | 38.48M |
| Float | 27.71M |
| Short Ratio | 8.63 |
| % Held by Insiders | 12.13% |
| % Held by Institutions | 50.19% |
| Shares Short | 213.89K |
| Short % of Float | 0.67% |
| Short % of Shares Outstanding | 0.54% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -33346.66% |
| Gross Margin | -150.00000000000000000000000000000000% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -23.48% |
| Return on Equity (ttm) | -45.029% |
Income Statement
| Revenue (ttm) | 70K USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | 76.50% |
| Gross Profit (ttm) | -105000 USD |
| EBITDA | -36543000 USD |
| Net Income Avi to Common (ttm) | -33233000 USD |
| Diluted EPS (ttm) | -0.66 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 46.45M USD |
| Total Cash Per Share (mrq) | 1.18 USD |
| Total Debt (mrq) | 3M USD |
| Total Debt/Equity (mrq) | 5.05 USD |
| Current Ratio (mrq) | 1.976 |
| Book Value Per Share (mrq) | 1.506 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -27682000 USD |
| Levered Free Cash Flow (ttm) | -18889624 USD |
Profile of Sera Prognostics
| Country | United States |
| State | UT |
| City | Salt Lake City |
| Address | 2749 East Parleys Way |
| ZIP | 84109 |
| Phone | 801 990 0520 |
| Website | https://www.sera.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 71 |
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Q&A For Sera Prognostics Stock
What is a current SERA stock price?
Sera Prognostics SERA stock price today per share is 2 USD.
How to purchase Sera Prognostics stock?
You can buy SERA shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sera Prognostics?
The stock symbol or ticker of Sera Prognostics is SERA.
Which industry does the Sera Prognostics company belong to?
The Sera Prognostics industry is Medical Devices.
How many shares does Sera Prognostics have in circulation?
The max supply of Sera Prognostics shares is 39.45M.
What is Sera Prognostics Price to Earnings Ratio (PE Ratio)?
Sera Prognostics PE Ratio is now.
What was Sera Prognostics earnings per share over the trailing 12 months (TTM)?
Sera Prognostics EPS is -0.67 USD over the trailing 12 months.
Which sector does the Sera Prognostics company belong to?
The Sera Prognostics sector is Healthcare.
Sera Prognostics SERA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27477.31 USD — |
+1.05
|
7.04B USD — | 27223.49 USD — | 27544.06 USD — | — - | 7.04B USD — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
|
US Tech Global Market Composite
NQGM
US
|
2175.08 USD — |
+0.37
|
— — | 2149.5 USD — | 2176.56 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
7022.12 USD — |
+1.07
|
— — | 6892.36 USD — | 7043.1 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1320 USD — |
+1.33
|
— — | 1298.21 USD — | 1322.56 USD — | — - | — — |
- {{ link.label }} {{link}}
